Skye Bioscience SKYE
NASDAQ SKYE
$1.68 +0.08 (+5.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Skye Bioscience (SKYE) Return on Capital Employed [ROCE] (2013 - 2026)

Updated

Skye Bioscience (SKYE) reported Return on Capital Employed [ROCE] of -1404.80% for Q2 2026, down 1313.83 percentage points from -90.98% a year earlier and down 965.89 percentage points from the prior quarter.

Analysis

Skye Bioscience (SKYE) Return on Capital Employed [ROCE] (2013 - 2026) Analysis & Trends

For FY2025, Skye Bioscience posted Return on Capital Employed [ROCE] of -137.39%, down 57.97 percentage points from FY2024.

  • Return on Capital Employed [ROCE] has a five-year change of +269.13 percentage points (FY2020 to FY2025).
  • By year, Return on Capital Employed [ROCE] came in at -79.43% in FY2024 and -333.78% in FY2021 (+72.74 pp).
  • The Q2 2026 figure ranks as the lowest quarterly Return on Capital Employed [ROCE] since Q3 2016.
  • Year over year, Return on Capital Employed [ROCE] has now declined in each of the last five quarters, with an average year-over-year change of -329.06 percentage points over the last six quarters.
  • The high point for year-over-year Return on Capital Employed [ROCE] in five years was Q3 2021 (a gain of 537.75 percentage points); the low point was Q2 2026 (a drop of 1313.83 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -438.91% (Q1 2026), -218.55% (Q4 2025) and -140.55% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 17.83%
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 17.92%
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 19.32%
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 9.54%
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 16.66%
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn -5.97%
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 11.86%
10 Skye Bioscience 7.03 Mn 7.03 Mn - -1,404.80%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1,404.80%
Mar 31, 2026 -438.91%
Dec 31, 2025 -218.55%
Sep 30, 2025 -140.55%
Jun 30, 2025 -90.98%
Mar 31, 2025 -56.41%
Dec 31, 2024 -41.47%
Sep 30, 2024 -29.98%
Jun 30, 2024 -56.50%
Mar 31, 2024 -100.53%
Jun 30, 2022 -1,218.88%
Mar 31, 2022 -206.80%
Dec 31, 2021 -114.42%
Sep 30, 2021 -94.62%
Jun 30, 2021 -164.92%
Mar 31, 2021 -219.36%
Dec 31, 2020 -230.92%
Sep 30, 2020 -632.37%
Dec 31, 2019 -745.17%
Mar 31, 2018 -243.02%
API Access

Skye Bioscience Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=SKYE&period=max&api_key=YOUR_API_KEY